02-08-2022 16:30 via medpagetoday.com

Long-Acting Ivabradine; Personalized DAPT Strategy Flops; Meth and Heart Disease

(MedPage Today) -- A long-acting formulation of ivabradine improved heart function in patients with heart failure with reduced ejection fraction, the FIRST trial showed. (Journal of the American College of Cardiology)
Nature looks at the state...
Read more »